Peters, Yonne
Al-Kaabi, Ali
Shaheen, Nicholas J.
Chak, Amitabh
Blum, Andrew
Souza, Rhonda F.
Di Pietro, Massimiliano
Iyer, Prasad G.
Pech, Oliver
Fitzgerald, Rebecca C.
Siersema, Peter D.
Article History
First Online: 23 May 2019
Competing interests
: N.J.S. has received research grants from Medtronic, CSA Medical, C2 Therapeutics, CDx Medical, EndoStim and Interpace Diagnostics and has served as a consultant for Pfizer, Boston Scientific and Shire. A.C. has equity interest in and is a consultant for Lucid Diagnostics. R.F.S. has served as a consultant and receives research support from Ironwood Pharmaceuticals. M.D.P. has received educational grants from Olympus and Medtronic and has served as consultant for Medtronic. P.G.I. has received research funding from Exact Sciences, Pentax Medical, Symple Surgical, Nine Point Medical and Medtronic and has served as a consultant for Medtronic, Symple Surgical and CSA Medical. O.P. has a speaker honorarium from Olympus, Fujifilm, Medtronic, Boston Scientific and Cook. R.C.F. is named on patents related to the Cytosponge and associated assays, which have been licensed to Covidien (now Medtronic), and has served as a consultant to Medtronic. P.D.S. has received research funding from Pentax Medical, EndoStim, Yakult, OncoDNA and Ella-CS. Y.P., A.A.-K. and A.B. declare no competing interests.